SYNAPTICS officer sells 612 shares in open-market trade

SYNAPTICS Inc officer Lisa Bodensteiner reported an open-market sale of 612 shares of Common Stock at $114.83 per share.

Rhea-AI Filing Summary

SYNAPTICS Inc officer Lisa Bodensteiner reported an open-market sale of 612 shares of Common Stock at $114.83 per share. The transaction was executed on May 19, 2026 and was made pursuant to a Rule 10b5-1 trading plan dated September 9, 2025. After this sale, she directly holds 63,106 shares of SYNAPTICS Common Stock.

Insider Trade Summary 10b5-1

Net Seller: 612 shares

Net Sell 1 txn

Insider Bodensteiner Lisa

Role See Remarks

Sold 612 shs ($70K)

Type	Security	Shares	Price	Value
Sale	Common Stock	612	$114.83	$70K

Holdings After Transaction: Common Stock — 63,106 shares (Direct)

Footnotes (1)

1. F1. The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

Key Figures

Shares sold: 612 shares Sale price: $114.83 per share Post-transaction holdings: 63,106 shares +2 more

5 metrics

Shares sold 612 shares Open-market sale of Common Stock on May 19, 2026

Sale price $114.83 per share Price for SYNAPTICS Common Stock in reported sale

Post-transaction holdings 63,106 shares Direct ownership after reported sale

Transaction direction Net sell of 612 shares transactionSummary shows net-sell direction

Trading plan type Rule 10b5-1 Trading Plan Footnote describes pre-arranged trading plan

Key Terms

Rule 10b5-1 Trading Plan, Form 4, open-market sale, Common Stock

4 terms

Rule 10b5-1 Trading Plan regulatory

"The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"was disclosed in a Form 4 insider trading report"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did SYNAPTICS (SYNA) report for Lisa Bodensteiner?

SYNAPTICS officer Lisa Bodensteiner sold 612 shares of Common Stock. The open-market sale occurred on May 19, 2026 at a price of $114.83 per share, and was disclosed in a Form 4 insider trading report.

At what price were the SYNAPTICS (SYNA) shares sold in this Form 4?

The reported SYNAPTICS shares were sold at $114.83 each. Lisa Bodensteiner executed an open-market sale of 612 shares of Common Stock at this price, according to the Form 4 transaction details.

How many SYNAPTICS (SYNA) shares does Lisa Bodensteiner hold after the sale?

After the reported sale, Lisa Bodensteiner directly holds 63,106 SYNAPTICS shares. The Form 4 lists this post-transaction ownership following the open-market sale of 612 shares of Common Stock.

Was the SYNAPTICS (SYNA) insider sale under a Rule 10b5-1 plan?

Yes, the sale was made under a Rule 10b5-1 trading plan. The footnote explains the 612-share sale was executed pursuant to a 10b5-1 Trading Plan dated September 9, 2025, indicating the transactions were pre-arranged.

Does the SYNAPTICS (SYNA) Form 4 show any option exercises or derivatives?

No derivative transactions are listed in this Form 4 excerpt. The filing reports only a single non-derivative open-market sale of 612 shares and shows no remaining derivative positions in the derivativeSummary section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 01:36 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bodensteiner Lisa

(Last) (First) (Middle)

1109 MCKAY DRIVE

(Street)

SAN JOSE CALIFORNIA 95131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SYNAPTICS Inc [ SYNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		S		612(1)	D	$114.83	63,106	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to 10b5-1 Trading Plan dated September 9, 2025.

Remarks:

The reporting person is Senior Vice President, Chief Legal Officer and Corporate Secretary.

	/s/ Pamela Fields, as attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)